Table 8.

Recommended therapies specified by each guideline for specific populations [3–11]

Black squares refer to initial therapy recommendations; grey squares refer to 2nd line therapy recommendations

C CHEP, T Taiwan, A ASH/ISH, E ESH/ESC, J JNC8, N NICE, CH China, AH AHA/ACC/CDC, F France, AHA/ACC/CDC American Hypertension Association/American College of Cardiology/Centers for Disease Control and Prevention, ASH/ISH American Society of Hypertension/International Society of Hypertension, CHEP Canadian hypertension education program, ESH/ESC European Society of Hypertension/European Society of Cardiology, JNC 8 Eighth Joint National Committee, NICE National Institute for Clinical Excellence (UK), ACEI angiotensin converting enzyme inhibitor, AF atrial fibrillation, ARB angiotensin receptor blocker, CCB calcium channel blocker, ESRD end-stage renal disease, ISH isolated systolic hypertension